Description

Goserelin EP Impurity E is the impurity of Goserelin (HY-13673)[1].—Cancer-programmed cell death–C58H83N17O13—-[1]Kripa S. Srivastava, et al. Solid phase peptide synthesis process for the production of goserelin. Patent WO2010141276A1.–147688-42-4–1226.39—-O=C([C@H]1NC(CC1)=O)N[C@@H](CC2=CN=CN2)C(N[C@H](C(N[C@@H](CO)C(N[C@H](C(N[C@H](COC(C)(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N3[C@@H](CCC3)C(NN)=O)=O)=O)=O)=O)CC4=CC=C(C=C4)O)=O)=O)CC5=CNC6=CC=CC=C56)=O–Cancer–H2O–Others—-Others–Peptides